Home
/
GILEAD SCIENCES, INC.
/
Financials
/
Quarterly
GILEAD SCIENCES, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that GILEAD SCIENCES, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Sep 30, 2020
$6.58B
Nov 4, 2020
Q2
2020
Jun 30, 2020
$5.14B
Aug 6, 2020
Q1
2020
Mar 31, 2020
$5.55B
May 6, 2020
Q3
2020
Sep 30, 2019
$5.60B
Nov 4, 2020
Q2
2020
Jun 30, 2019
$5.69B
Aug 6, 2020
Q1
2020
Mar 31, 2019
$5.28B
May 6, 2020
Q3
2019
Sep 30, 2018
$5.60B
Nov 5, 2019
Q2
2019
Jun 30, 2018
$5.65B
Aug 6, 2019
Q1
2019
Mar 31, 2018
$5.09B
May 8, 2019
Q3
2018
Sep 30, 2017
$6.51B
Nov 6, 2018
Q2
2018
Jun 30, 2017
$7.14B
Aug 6, 2018
Q2
2013
Jun 30, 2013
$2.77B
Aug 1, 2013
Q1
2013
Mar 31, 2013
$2.53B
May 8, 2013
Q3
2012
Sep 30, 2012
$2.43B
Nov 6, 2012
Q2
2013
Jun 30, 2012
$2.41B
Aug 1, 2013
Q1
2013
Mar 31, 2012
$2.28B
May 8, 2013
Q3
2012
Sep 30, 2011
$2.12B
Nov 6, 2012
Q2
2012
Jun 30, 2011
$2.14B
Aug 1, 2012
Q1
2012
Mar 31, 2011
$1.93B
May 4, 2012
Q3
2011
Sep 30, 2010
$1.94B
Nov 4, 2011
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$7.77B
Nov 7, 2025
Q2
2025
Jun 30, 2025
$7.08B
Aug 7, 2025
Q1
2025
Mar 31, 2025
$6.67B
May 7, 2025
Q3
2025
Sep 30, 2024
$7.55B
Nov 7, 2025
Q2
2025
Jun 30, 2024
$6.95B
Aug 7, 2025
Q1
2025
Mar 31, 2024
$6.69B
May 7, 2025
Q3
2024
Sep 30, 2023
$7.05B
Nov 12, 2024
Q2
2024
Jun 30, 2023
$6.60B
Aug 8, 2024
Q1
2024
Mar 31, 2023
$6.35B
May 8, 2024
Q3
2023
Sep 30, 2022
$7.04B
Nov 7, 2023
Q2
2023
Jun 30, 2022
$6.26B
Aug 4, 2023
Q1
2023
Mar 31, 2022
$6.59B
May 3, 2023
Q3
2022
Sep 30, 2021
$7.42B
Nov 2, 2022
Q2
2022
Jun 30, 2021
$6.22B
Aug 8, 2022
Q1
2022
Mar 31, 2021
$6.42B
May 4, 2022
Q3
2021
Sep 30, 2020
$6.58B
Nov 3, 2021
Q2
2021
Jun 30, 2020
$5.14B
Aug 5, 2021
Q1
2021
Mar 31, 2020
$5.55B
May 6, 2021
Q3
2019
Sep 30, 2019
$5.60B
Nov 5, 2019
Q2
2019
Jun 30, 2019
$5.69B
Aug 6, 2019
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$5.09B
May 9, 2018
Q3
2017
Sep 30, 2017
$6.51B
Nov 7, 2017
Q2
2017
Jun 30, 2017
$7.14B
Aug 7, 2017
Q1
2018
Mar 31, 2017
$6.51B
May 9, 2018
Q3
2017
Sep 30, 2016
$7.50B
Nov 7, 2017
Q2
2017
Jun 30, 2016
$7.78B
Aug 7, 2017
Q1
2017
Mar 31, 2016
$7.79B
May 10, 2017
Q3
2016
Sep 30, 2015
$8.30B
Nov 7, 2016
Q2
2016
Jun 30, 2015
$8.24B
Aug 5, 2016
Q1
2016
Mar 31, 2015
$7.59B
May 6, 2016
Q3
2015
Sep 30, 2014
$6.04B
Nov 4, 2015
Q2
2015
Jun 30, 2014
$6.54B
Aug 5, 2015
Q1
2015
Mar 31, 2014
$5.00B
May 8, 2015
Q3
2014
Sep 30, 2013
$2.78B
Nov 5, 2014
Q2
2014
Jun 30, 2013
$2.77B
Aug 4, 2014
Q1
2014
Mar 31, 2013
$2.53B
May 7, 2014
Q3
2013
Sep 30, 2012
$2.43B
Oct 31, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.05B
Nov 7, 2025
Q2
2025
Jun 30, 2025
$1.96B
Aug 7, 2025
Q1
2025
Mar 31, 2025
$1.32B
May 7, 2025
Q3
2025
Sep 30, 2024
$1.25B
Nov 7, 2025
Q2
2025
Jun 30, 2024
$1.61B
Aug 7, 2025
Q1
2025
Mar 31, 2024
($4.17B)
May 7, 2025
Q3
2024
Sep 30, 2023
$2.18B
Nov 12, 2024
Q2
2024
Jun 30, 2023
$1.05B
Aug 8, 2024
Q1
2024
Mar 31, 2023
$1.01B
May 8, 2024
Q3
2023
Sep 30, 2022
$1.79B
Nov 7, 2023
Q2
2023
Jun 30, 2022
$1.14B
Aug 4, 2023
Q1
2023
Mar 31, 2022
$19.00M
May 3, 2023
Q3
2022
Sep 30, 2021
$2.59B
Nov 2, 2022
Q2
2022
Jun 30, 2021
$1.52B
Aug 8, 2022
Q1
2022
Mar 31, 2021
$1.73B
May 4, 2022
Q3
2021
Sep 30, 2020
$360.00M
Nov 3, 2021
Q2
2021
Jun 30, 2020
($3.34B)
Aug 5, 2021
Q1
2021
Mar 31, 2020
$1.55B
May 6, 2021
Q3
2020
Sep 30, 2019
($1.17B)
Nov 4, 2020
Q2
2020
Jun 30, 2019
$1.88B
Aug 6, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.33B
Nov 7, 2025
Q2
2025
Jun 30, 2025
$2.47B
Aug 7, 2025
Q1
2025
Mar 31, 2025
$2.24B
May 7, 2025
Q3
2025
Sep 30, 2024
$888.00M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$2.64B
Aug 7, 2025
Q1
2025
Mar 31, 2024
($4.32B)
May 7, 2025
Q3
2024
Sep 30, 2023
$2.62B
Nov 12, 2024
Q2
2024
Jun 30, 2023
$1.67B
Aug 8, 2024
Q1
2024
Mar 31, 2023
$1.71B
May 8, 2024
Q3
2023
Sep 30, 2022
$2.84B
Nov 7, 2023
Q2
2023
Jun 30, 2022
$2.03B
Aug 4, 2023
Q1
2023
Mar 31, 2022
$197.00M
May 3, 2023
Q3
2022
Sep 30, 2021
$3.84B
Nov 2, 2022
Q2
2022
Jun 30, 2021
$2.25B
Aug 8, 2022
Q1
2022
Mar 31, 2021
$2.89B
May 4, 2022
Q3
2021
Sep 30, 2020
$2.00B
Nov 3, 2021
Q2
2021
Jun 30, 2020
($2.98B)
Aug 5, 2021
Q1
2021
Mar 31, 2020
$2.40B
May 6, 2021
Q3
2020
Sep 30, 2019
($1.47B)
Nov 4, 2020
Q2
2020
Jun 30, 2019
$2.43B
Aug 6, 2020